Temporary Policies for Compounding Certain Parenteral Drug Products: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 11, 2024
October 17, 2024
46ee42bb-92f0-47bf-a6e8-2980ea59392a
Related Documents
Temporary Policies for Compounding Certain Starter Parenteral Nutrition Drug Products for Neonates: Guidance for Industry
Guidance DocumentSeptember 8, 2026Center for Drug Evaluation and Research
Testing of Glycerin, Propylene Glycol, Maltitol Solution, Hydrogenated Starch Hydrolysate, Sorbitol Solution, and Other High-Risk Drug Components for Diethylene Glycol and Ethylene Glycol
Guidance DocumentMay 8, 2023Center for Drug Evaluation and Research
Compounding Certain Ibuprofen Oral Suspension Products Under Section 503B of the Federal Food, Drug, and Cosmetic Act
Guidance DocumentFebruary 9, 2023Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.